ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The BCL2/BAX/ROS pathway is involved in the inhibitory effect of astragaloside IV on pyroptosis in human umbilical vein endothelial cells

Su, Yi; Yin, Xin; Huang, Xin; Guo, Qianqian; Ma, Mingyuan; Guo, Liheng*广州中医药大学
PHARMACEUTICAL BIOLOGY2022-12-31DOI: 10.1080/13880209.2022.2101668
6被引17阅读
引用收藏
分享

摘要

Context Astragaloside IV (AS-IV) is extracted from Astragalus membranaceus (Fisch.) Bunge (Fabaceae). However, its effects on endothelial cell injury remain unclear. Objective To investigate the mechanisms underlying the effects of AS-IV on lipopolysaccharide (LPS)-induced endothelial injury in vitro. Materials and methods Human umbilical vein endothelial cells (HUVECs) were pre-treated with AS-IV (100 mu mol/mL), 4-hydroxy-3-methoxyacetophenone (APO, 10 mu mol/mL), N-acetylcysteine (NAC, 50 mu mol/mL) and Ac-YVAD-cmk (AC, 5 mu mol/mL) for 2 h before 1 mu g/mL LPS 24 h exposure. Untreated cells cultured without any exposure were used as controls. Cell viability, reactive oxygen species (ROS) and pyroptosis assays were performed. The pyroptosis related proteins were detected by western blot. Results The rate in late pyroptosis (Q2-2) of AS-IV (13.65 +/- 0.74%), APO (13.69 +/- 0.67%) and NAC (15.87 +/- 0.46%) groups was lower than the LPS group (21.89 +/- 0.66%, p < 0.05), while the rate in early pyroptosis (Q2-4) of AS-IV group (12.00 +/- 0.26%) was lower than other groups (p < 0.05). The expression of NOX4, GSDMD, NLRP3, ASC and caspase-1 decreased after AS-IV, NAC or AC intervention (p < 0.05). The ROS production in AS-IV (4664 +/- 153.20), APO (4094 +/- 78.37), NAC (5103 +/- 131.10) and AC (3994 +/- 102.50) groups was lower than the LPS (5986 +/- 127.30) group, while the mitochondrial BCL2/BAX protein expression ratio increased in AS-IV, APO and NAC groups (p < 0.05). Discussion and conclusions AS-IV suppressed pyroptosis in LPS-activated HUVECs by inducing ROS/NLRP3-mediated inhibition of the inflammatory response, providing a scientific basis for clinical applications of AS-IV.

学科与关键词

关键词
Sepsislipopolysaccharidemitochondriainflammasomeendothelial injury
相关
加载中…
  • Astragaloside IV ameliorates sepsis-induced myocardial dysfunction by regulating NOX4/JNK/BAX pathway
    Su, Yi; Yin, Xin; Huang, Xin; Guo, Qianqian; Ma, Mingyuan; Guo, Liheng*Life Sciences, 2022, 310: 121123.被引 5
  • Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy
    Li, Huijun; Xu, Jialin; Zhang, Yanan; Hong, Lei; He, Zhijian; Zeng, Zhiheng*; Zhang, Li*Human Cell, 2022, 35(6): 1684-1696.被引 4
  • Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway
    Su, Yanyan; Xu, Jiaqi; Chen, Siqi; Feng, Junxia; Li, Jingchun; Lei, Zihan; Qiao, Lingyan; Wang, Yaning*; Zeng, Dewang*Translational Andrology and Urology, 2022, 11(8): 1177-1188.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
PHARMACEUTICAL BIOLOGY
发表日期
2022-12-31
卷期
第 60 卷, 第 1 期
页码
1812-1818
DOI
10.1080/13880209.2022.2101668
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [8167140184, 82074216, 81703848, 81673702, 82004135]; GuangDong Basic and Applied Basic Research Foundation (Business Consortium Fund) [2021A1515220035]; Natural Science Foundation of Guangdong Province, China [2016A030313636, 2017A030313725]; Chinese Medicine Bureau of Guangdong Province [20201144]; SHI Zaixiang Academic Thought Inheritance Studio [201489]; Project of Guangdong Provincial Hospital of Chinese Medicine [E43717]; CHEN Ke-ji Academic Thought Inheritance Studio [2014-89]; Foshan Medical Science and Technology Project [1920001000307]; Medical Research Project of Foshan Health Bureau [20210169]; 2022 Foshan Competitive Support Talent Project; Teaching Demonstration Center of Integrated Traditional Chinese and Western Medicine in Critical Medicine [A1-afd015161z0753]

作者

  • S

    Su, Yi (第一作者)

    foshan hosp tradit chinese med · guangzhou univ chinese med · 2

  • Y

    Yin, Xin

    2 · guangzhou univ chinese med

查看全部 6 位作者收起作者
  • H

    Huang, Xin

    2 · guangzhou univ chinese med

  • G

    Guo, Qianqian

    2 · guangzhou univ chinese med

  • M

    Ma, Mingyuan

    foshan hosp tradit chinese med · guangzhou univ chinese med

  • G

    Guo, Liheng (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417